| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.29▲ | 7.27▲ | 7.27▲ | 7.21▲ | 6.86▲ |
| MA10 | 7.27▲ | 7.22▲ | 7.23▲ | 7.20▲ | 6.41▲ |
| MA20 | 7.20▲ | 7.14▲ | 7.13▲ | 6.74▲ | 6.82▲ |
| MA50 | 7.22▲ | 7.16▲ | 7.06▲ | 6.32▲ | 5.87▲ |
| MA100 | 7.07▲ | 6.77▲ | 6.61▲ | 6.78▲ | 5.80▲ |
| MA200 | 6.57▲ | 6.33▲ | 6.38▲ | 5.76▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.015▲ | 0.021▲ | 0.012▲ | 0.043▲ | 0.025▲ |
| RSI | 56.671▲ | 57.708▲ | 58.222▲ | 63.793▲ | 57.356▲ |
| STOCH | 82.239▲ | 80.310▲ | 83.158▲ | 55.873 | 61.809 |
| WILL %R | -4.545▲ | -3.571▲ | -2.703▲ | -28.571 | -15.966▲ |
| CCI | 75.055 | 108.794▲ | 106.011▲ | 72.902 | 120.103▲ |
|
Monday, November 23, 2020 06:05 AM
Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it has entered into a debt financing ...
|
|
Monday, November 23, 2020 12:01 AM
LONDON and RALEIGH, N.C., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company focused on ...
|
|
Sunday, November 08, 2020 11:11 PM
© 2020 Insider Inc. and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service and ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/11/20 | 7.30 | 7.31 | 7.30 | 7.31 | 12,018 |
| 27/11/20 | 7.26 | 7.29 | 7.20 | 7.23 | 24,561 |
| 25/11/20 | 7.19 | 7.30 | 6.96 | 7.26 | 11,800 |
| 24/11/20 | 6.97 | 7.35 | 6.97 | 7.24 | 128,814 |
| 23/11/20 | 7.30 | 7.40 | 6.98 | 7.02 | 73,283 |
| 20/11/20 | 7.30 | 7.39 | 6.96 | 7.05 | 53,366 |
| 19/11/20 | 7.65 | 7.69 | 7.08 | 7.34 | 56,164 |
| 18/11/20 | 7.12 | 7.68 | 7.0405 | 7.55 | 119,382 |
| 17/11/20 | 6.90 | 7.29 | 6.87 | 7.20 | 108,936 |
| 16/11/20 | 6.63 | 6.79 | 6.60 | 6.79 | 14,516 |
|
|
||||
|
|
||||
|
|